NeoCor JSC designes and manufactures implants applied in cardiovascular surgery from animal tissues under the license for medical devices manufacture No. FS-99-04-006051 dated November 13, 2018, issued by the Federal Service for Supervision in the Sphere of Health Care of the Russian Federation.
The cardiovascular surgery biological prostheses production lab has been in business for more than 30 years and holds leading positions in this field. During this time, the company's employees have gained extensive experience in the sphere of cardiovascular implants design and production.
In 2003, company's quality management system “Design and manufacture of prostheses for cardiovascular surgery” was certified for compliance with ISO 9001:2008. The company was the first Russian medical devices manufacturer to successfully gain such certification. In 2018, the company gained certification for its quality management system to ISO 13485:2016 “Medical Devices. Quality management systems. Requirements for regulatory purposes”.
Company's basic principles include:
- Designing new medical devices and improving the existing ones in cooperation with surgeons;
- Marketing effective and safe medical devices while maintaining optimal prices;
- Timely products delivery and meeting special shipment and storage requirements.
Company's products are used in clinics throughout Russia from Kaliningrad to Vladivostok.
According to the state contracts signed by cardiac surgery clinics in 2018, every third heart valve bioprosthesis purchased by Russian clinics was manufactured in NeoCor production lab.
Watch a video made in NeoCor production lab to learn the manufacturing process of bioprostheses for cardiovascular surgery.